310 related articles for article (PubMed ID: 26694854)
21. Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells.
Seto E; Moosmann A; Grömminger S; Walz N; Grundhoff A; Hammerschmidt W
PLoS Pathog; 2010 Aug; 6(8):e1001063. PubMed ID: 20808852
[TBL] [Abstract][Full Text] [Related]
22. Comprehensive profiling of functional Epstein-Barr virus miRNA expression in human cell lines.
Hooykaas MJ; Kruse E; Wiertz EJ; Lebbink RJ
BMC Genomics; 2016 Aug; 17():644. PubMed ID: 27531524
[TBL] [Abstract][Full Text] [Related]
23. Functional analysis of the mutated Epstein-Barr virus oncoprotein LMP1(69del): implications for a new role of naturally occurring LMP1 variants.
Larcher C; Bernhard D; Schaadt E; Adler B; Ausserlechner MJ; Mitterer M; Huemer HP
Haematologica; 2003 Dec; 88(12):1324-35. PubMed ID: 14687985
[TBL] [Abstract][Full Text] [Related]
24. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
25. Next-generation sequencing of miRNAs in clinical samples of Epstein-Barr virus-associated B-cell lymphomas.
Sakamoto K; Sekizuka T; Uehara T; Hishima T; Mine S; Fukumoto H; Sato Y; Hasegawa H; Kuroda M; Katano H
Cancer Med; 2017 Mar; 6(3):605-618. PubMed ID: 28181423
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus microRNAs reduce immune surveillance by virus-specific CD8+ T cells.
Albanese M; Tagawa T; Bouvet M; Maliqi L; Lutter D; Hoser J; Hastreiter M; Hayes M; Sugden B; Martin L; Moosmann A; Hammerschmidt W
Proc Natl Acad Sci U S A; 2016 Oct; 113(42):E6467-E6475. PubMed ID: 27698133
[TBL] [Abstract][Full Text] [Related]
27. Genetics of Epstein-Barr virus microRNAs.
Klinke O; Feederle R; Delecluse HJ
Semin Cancer Biol; 2014 Jun; 26():52-9. PubMed ID: 24602823
[TBL] [Abstract][Full Text] [Related]
28. Regulation network and expression profiles of Epstein-Barr virus-encoded microRNAs and their potential target host genes in nasopharyngeal carcinomas.
Zeng Z; Huang H; Huang L; Sun M; Yan Q; Song Y; Wei F; Bo H; Gong Z; Zeng Y; Li Q; Zhang W; Li X; Xiang B; Li X; Li Y; Xiong W; Li G
Sci China Life Sci; 2014 Mar; 57(3):315-326. PubMed ID: 24532457
[TBL] [Abstract][Full Text] [Related]
29. Analysis of Viral and Cellular MicroRNAs in EBV-Infected Cells.
Skalsky RL
Methods Mol Biol; 2017; 1532():133-146. PubMed ID: 27873272
[TBL] [Abstract][Full Text] [Related]
30. A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia.
Qiu J; Cosmopoulos K; Pegtel M; Hopmans E; Murray P; Middeldorp J; Shapiro M; Thorley-Lawson DA
PLoS Pathog; 2011 Aug; 7(8):e1002193. PubMed ID: 21901094
[TBL] [Abstract][Full Text] [Related]
31. Conserved sequences of BART and BHRF regions encoding viral microRNAs in Epstein-Barr virus-associated lymphoma.
Sunagawa K; Hishima T; Fukumoto H; Hasegawa H; Katano H
BMC Res Notes; 2017 Jul; 10(1):279. PubMed ID: 28705173
[TBL] [Abstract][Full Text] [Related]
32. An Epstein-Barr Virus MicroRNA Blocks Interleukin-1 (IL-1) Signaling by Targeting IL-1 Receptor 1.
Skinner CM; Ivanov NS; Barr SA; Chen Y; Skalsky RL
J Virol; 2017 Nov; 91(21):. PubMed ID: 28794034
[TBL] [Abstract][Full Text] [Related]
33. Natural Variation of Epstein-Barr Virus Genes, Proteins, and Primary MicroRNA.
Correia S; Palser A; Elgueta Karstegl C; Middeldorp JM; Ramayanti O; Cohen JI; Hildesheim A; Fellner MD; Wiels J; White RE; Kellam P; Farrell PJ
J Virol; 2017 Aug; 91(15):. PubMed ID: 28515295
[TBL] [Abstract][Full Text] [Related]
34. Biogenesis of Epstein-Barr virus microRNAs.
Kim DN; Lee SK
Mol Cell Biochem; 2012 Jun; 365(1-2):203-10. PubMed ID: 22350759
[TBL] [Abstract][Full Text] [Related]
35. Epstein-Barr Virus (EBV)-BamHI-A Rightward Transcript (BART)-6 and Cellular MicroRNA-142 Synergistically Compromise Immune Defense of Host Cells in EBV-Positive Burkitt Lymphoma.
Zhou L; Bu Y; Liang Y; Zhang F; Zhang H; Li S
Med Sci Monit; 2016 Oct; 22():4114-4120. PubMed ID: 27796281
[TBL] [Abstract][Full Text] [Related]
36. Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice.
Coleman CB; Lang J; Sweet LA; Smith NA; Freed BM; Pan Z; Haverkos B; Pelanda R; Rochford R
J Virol; 2018 Nov; 92(21):. PubMed ID: 30089703
[TBL] [Abstract][Full Text] [Related]
37. Spontaneous lymphoblastoid cell lines from patients with Epstein-Barr virus infection show highly variable proliferation characteristics that correlate with the expression levels of viral microRNAs.
Delecluse S; Yu J; Bernhardt K; Haar J; Poirey R; Tsai MH; Kiblawi R; Kopp-Schneider A; Schnitzler P; Zeier M; Dreger P; Wuchter P; Bulut OC; Behrends U; Delecluse HJ
PLoS One; 2019; 14(9):e0222847. PubMed ID: 31568538
[TBL] [Abstract][Full Text] [Related]
38. EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency.
Riley KJ; Rabinowitz GS; Yario TA; Luna JM; Darnell RB; Steitz JA
EMBO J; 2012 May; 31(9):2207-21. PubMed ID: 22473208
[TBL] [Abstract][Full Text] [Related]
39. Epstein-Barr virus induces global changes in cellular mRNA isoform usage that are important for the maintenance of latency.
Homa NJ; Salinas R; Forte E; Robinson TJ; Garcia-Blanco MA; Luftig MA
J Virol; 2013 Nov; 87(22):12291-301. PubMed ID: 24027308
[TBL] [Abstract][Full Text] [Related]
40. Latent Membrane Protein 1 (LMP1) from Epstein-Barr Virus (EBV) Strains M81 and B95.8 Modulate miRNA Expression When Expressed in Immortalized Human Nasopharyngeal Cells.
Müller Coan BG; Cesarman E; Acencio ML; Elgui de Oliveira D
Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205397
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]